Hepatic Insulin Resistance & Nonalcoholic Fatty Liver Disease -

Hepatic Insulin Resistance & Nonalcoholic Fatty Liver Disease

Buch | Softcover
85 Seiten
2011
Nova Science Publishers Inc (Verlag)
978-1-61209-528-8 (ISBN)
92,60 inkl. MwSt
Hepatic Insulin Resistance & Nonalcoholic Fatty Liver Disease
Insulin resistance (IR) and metabolic syndrome are associated with the pathogenesis and progression of non-alcoholic fatty liver disease (NAFLD). It encompasses a spectrum of hepatic pathology, ranging from simple steatosis in its most benign form (fatty liver), going through nonalcoholic steatohepatitis (NASH) in its intermediate form, until cirrhosis and hepatocellular carcinoma, its most advanced forms. This book presents current research on the background of fatty acid oxidation; hepatic steatosis and its progression to NASH and cirrhosis; fibrosis and myofibroblastic cells differentiation; methods of diagnosis; clinical features and laboratory tests and, finally, rodent NAFLD and NASH models.

Introduction; Triglyceride Storage Regulation in Hepatocytes; Impairment of Fatty Acid Oxidation; NAFLD & Its Progression to NASH & Cirrhosis; Steatosis; Inflammation; Fibrosis & Myofibroblastic Cell Differentiation; Methods of Diagnosis; Rodent NAFLD & NASH Models; Conclusions; Index.

Verlagsort New York
Sprache englisch
Maße 230 x 155 mm
Gewicht 166 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hepatologie
ISBN-10 1-61209-528-3 / 1612095283
ISBN-13 978-1-61209-528-8 / 9781612095288
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Diagnostik, Differenzialdiagnostik, Therapieansätze

von Frank Fischbach; Katharina Fischbach

Buch (2016)
Thieme (Verlag)
101,00